SodC RibH Ndk L7/L12 MDH Vaccine composition for prevention or treatment of brucellosis comprising SodC RibH Ndk L7/L12 and MDH protein derived from Brucella abortus as effective component
INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY
发明人:
김석,KIM SUK
申请号：
KR1020180130315
公开号：
KR1020920410000B1
申请日:
2018.10.30
申请国别(地区):
KR
年份:
2020
代理人:
摘要：
The present invention, SodC (Cu, Zn superoxide dismutase), RibH (6,7-dimethyl-8-ribityllumazine synthase), Ndk (nucleoside diphosphate kinase), large subunit ribosomal proteins L7 / L12 and MDH (malate) derived from the Brucella abotus strain dehydrogenase) It relates to a subunit vaccine composition for preventing or treating brucellosis infection comprising the protein as an active ingredient.본 발명은 브루셀라 어보투스 균주 유래의 SodC(Cu, Zn superoxide dismutase), RibH(6,7-dimethyl-8-ribityllumazine synthase), Ndk(nucleoside diphosphate kinase), large subunit 리보솜 단백질 L7/L12 및 MDH(malate dehydrogenase) 단백질을 유효성분으로 포함하는 브루셀라 감염증 예방 또는 치료용 서브유닛 백신(subunit vaccine) 조성물에 관한 것이다.
